Esthesioneuroblastoma

On this page

Olfactory Oddity - Nose's Neural Nuisance

  • Rare, aggressive malignant tumor from olfactory neuroepithelium (neural crest origin) in the nasal vault.
  • Primary sites: Cribriform plate, superior nasal septum, superior turbinates.
  • AKA: Olfactory Neuroblastoma.
  • Symptoms: Progressive unilateral nasal obstruction, recurrent epistaxis, anosmia/hyposmia.
    • Advanced: Proptosis, diplopia, headache, facial pain.
  • Esthesioneuroblastoma in olfactory cleft region

⭐ Exhibits a characteristic bimodal age distribution, with peaks in the 2nd decade (10-20 yrs) and 6th decade (50-60 yrs).

Sniffle Signals - When Smells Go Wrong

  • Unilateral nasal obstruction: Most common, often progressive.
  • Epistaxis: Recurrent, sometimes profuse nosebleeds.
  • Anosmia/Hyposmia (loss/↓ smell): Key early sign.
  • Headache, facial pain/fullness: From tumor mass.
  • Proptosis, diplopia, ↓ vision: With orbital extension.
  • Cranial nerve palsies: With skull base invasion.
  • Watery rhinorrhea (CSF leak): Indicates dural involvement. Esthesioneuroblastoma: MRI, CT, and Endoscopic Views

⭐ Persistent unilateral nasal obstruction and/or epistaxis in an adult should raise suspicion for nasal malignancy, including esthesioneuroblastoma.

Picture Perfect - Pinpointing the Problem

Error: Failed to generate content for this concept group.

Battle Plan - Tackling the Tumor

  • Primary Goal: Complete en bloc surgical resection (R0) for cure.
  • Core Strategy: Multimodal - Surgery + Post-Operative Radiotherapy (PORT).
  • Surgical Approaches:
    • Craniofacial Resection (CFR): Gold standard for most; ensures wide margins.
    • Endoscopic Endonasal Approach (EEA): For selected, early-stage, central tumors.
  • Radiotherapy (RT):
    • PORT: Standard, dose ~50-66 Gy. Improves local control.

    ⭐ PORT is crucial post-surgery, even with R0 resection, significantly boosting local control & survival, especially for advanced Kadish stages.

  • Chemotherapy (CT):
    • Neoadjuvant (Cisplatin/Etoposide): For unresectable/bulky tumors to downstage.
    • Adjuvant/Palliative: For high-risk, recurrent, or metastatic disease.

Endoscopic Endonasal Approach for Esthesioneuroblastoma

Treatment Algorithm:

Future Focus - After the Fight

  • Lifelong Surveillance: Essential due to high recurrence risk.
    • Regular clinical exams, nasal endoscopy.
    • Periodic MRI/CT scans (e.g., annually post 5 years).
  • Recurrence:
    • Local: Salvage surgery, re-irradiation.
    • Regional/Distant: Systemic therapy.
  • Prognosis: Depends on Kadish stage, Hyams grade, resection completeness.
    • 5-year survival: ~60-80% (limited), ↓ with advanced disease.
  • Quality of Life: Manage olfactory loss, sinonasal symptoms.

⭐ Late recurrences (>5 years) are common, mandating indefinite surveillance.

High-Yield Points - ⚡ Biggest Takeaways

  • Origin: Olfactory neuroepithelium (superior nasal cavity); presents with nasal obstruction, epistaxis.
  • Bimodal age distribution: peaks at 10-20 years and 50-60 years.
  • Hyams grading (histopathology) and Kadish staging (clinical) guide prognosis and treatment.
  • Imaging: Classic "dumbbell" tumor via cribriform plate signifies intracranial spread.
  • Histopathology: Homer Wright rosettes are a characteristic finding.
  • Treatment: Craniofacial resection followed by adjuvant radiotherapy is standard.

Practice Questions: Esthesioneuroblastoma

Test your understanding with these related questions

Which of the following is an indication for Functional Endoscopic Sinus Surgery (FESS)?

1 of 5

Flashcards: Esthesioneuroblastoma

1/6

Surgical removal, Radiation or _____ can be used for the treatment of glomus jugulare tumors

TAP TO REVEAL ANSWER

Surgical removal, Radiation or _____ can be used for the treatment of glomus jugulare tumors

Embolization

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial